Clinical Trial Update: S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract [Phase 2]

View source ↗

Summary

Phase 2 trial update for S0031 (ZD 1839/Gefitinib) in advanced urinary tract cancers; the study is completed, evaluating activity in bladder cancer, urothelial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urethral Cancer
• Urothelial Carcinoma of the Renal Pelvis and Ureter

Drugs mentioned

• Gefitinib (Gefitinib)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: COMPLETED